| Literature DB >> 29606093 |
Domenico Palumbo1, Ornella Affinito2, Antonella Monticelli3, Sergio Cocozza2.
Abstract
BACKGROUND: In recent years, epigenetics has gained a central role in the understanding of the process of natural selection. It is now clear how environmental impacts on the methylome could promote methylation variability with direct effects on disease etiology as well as phenotypic and genotypic variations in evolutionary processes. To identify possible factors influencing inter-individual methylation variability, we studied methylation values standard deviation of 166 healthy individuals searching for possible associations with genomic features and evolutionary signatures.Entities:
Keywords: Blood; GERP-RS; Methylation; Selective pressure; Variability
Mesh:
Year: 2018 PMID: 29606093 PMCID: PMC5880022 DOI: 10.1186/s12864-018-4618-9
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1a CpGs methylation variation (MV) values distribution in EPIC cohort. b Boxplots of CpGs methylation variation (MV) and deciles of methylation values for all CpGs
Fig. 2Boxplots of CpGs methylation variation (MV) for CpGs cluster density
Gene Set Enrichment Analysis output for CpGs with high or low MV
| Gene set name | NOM | FDR q-val | MV |
|---|---|---|---|
| OLFACTORY TRANSDUCTION | 0.000 | 0.000 | High |
| GRAFT VERSUS HOST DISEASE | 0.000 | 0.000 | High |
| ALLOGRAFT REJECTION | 0.000 | 0.000 | High |
| ASTHMA | 0.000 | 0.000 | High |
| TYPE I DIABETES MELLITUS | 0.000 | 0.000 | High |
| NEUROACTIVE LIGAND RECEPTOR INTERACTION | 0.000 | 0.000 | High |
| AUTOIMMUNE THYROID DISEASE | 0.000 | 0.000 | High |
| INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION | 0.000 | 0.001 | High |
| METABOLISM OF XENOBIOTICS BY CYTOCHROME P450 | 0.000 | 0.018 | High |
| ANTIGEN PROCESSING AND PRESENTATION | 0.005 | 0.032 | High |
| DRUG METABOLISM CYTOCHROME P450 | 0.004 | 0.035 | High |
| CELL ADHESION MOLECULES CAMS | 0.002 | 0.033 | High |
| VIRAL MYOCARDITIS | 0.009 | 0.033 | High |
| COMPLEMENT AND COAGULATION CASCADES | 0.010 | 0.032 | High |
| RETINOL METABOLISM | 0.008 | 0.053 | High |
| CYTOKINE CYTOKINE RECEPTOR INTERACTION | 0.001 | 0.052 | High |
| SYSTEMIC LUPUS ERYTHEMATOSUS | 0.007 | 0.054 | High |
| LEISHMANIA INFECTION | 0.005 | 0.064 | High |
| SPLICEOSOME | 0.000 | 0.000 | Low |
| RNA DEGRADATION | 0.000 | 0.000 | Low |
| HOMOLOGOUS RECOMBINATION | 0.000 | 0.000 | Low |
| UBIQUITIN MEDIATED PROTEOLYSIS | 0.000 | 0.000 | Low |
| CELL CYCLE | 0.000 | 0.001 | Low |
| N-GLYCAN BIOSYNTHESIS | 0.000 | 0.004 | Low |
| PARKINSONS DISEASE | 0.000 | 0.006 | Low |
| RNA POLYMERASE | 0.003 | 0.007 | Low |
| LYSINE DEGRADATION | 0.000 | 0.009 | Low |
| HUNTINGTONS DISEASE | 0.000 | 0.013 | Low |
| PROTEASOME | 0.004 | 0.018 | Low |
| TERPENOID BACKBONE BIOSYNTHESIS | 0.003 | 0.017 | Low |
| OXIDATIVE PHOSPHORYLATION | 0.000 | 0.016 | Low |
| AMINOACYL TRNA BIOSYNTHESIS | 0.000 | 0.015 | Low |
| RIBOSOME | 0.000 | 0.018 | Low |
Fig. 3Boxplots of CpGs methylation variation (MV) values (y-axis) and quartiles of Genomic Evolutionary Rate Profiling (GERP) Rejected Score (RS) (x-axis)
Fig. 4Boxplots of CpGs methylation variation (MV) values between Recent Selective Pressure – CpGs (RSP-CpGs) in TSI and Non Recent Selective Pressure – CpGs (No RSP-CpGs)